SCHEMBL841683

SCHEMBL841683

Cc1c(O)cc(C(=O)O)c(C)c1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
CSNK2A1 P68400 1/20 0.45
ACHE P22303 1/20 0.45
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 2/20 0.42
PKM P14618 1/20 0.42
LDHA P00338 2/20 0.41
LDHB P07195 2/20 0.41
MYC P01106 2/20 0.41
MCL1 Q07820 2/20 0.40
SELL P14151 1/20 0.40
SELP P16109 1/20 0.40
MAPT P10636 1/20 0.39
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA7 P43166 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14989153 0.86 KDM4E (0.50) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL9042241 0.86 CYP3A4 (0.52) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL27534718 0.85 LDHA (0.44) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL5268292 0.83 CYP3A4 (0.50) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL4184562 0.83 CYP3A4 (0.45) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL23600937 0.80 CYP3A4 (0.52) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL6904405 0.80 KDM4E (0.45) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL2226009 0.77 KMT2A (0.42) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL10785106 0.77 LDHA (0.48) CYP3A4CSNK2A1ACHEKDM4EMEN1
SCHEMBL5262898 0.77 KDM4E (0.42) CYP3A4CSNK2A1ACHEKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119875090-A PEF hydrogen bond reinforced modified polyester material and preparation method thereof 万凯新材料股份有限公司 2025-04-25 CN claimed
EP-2788366-B1 PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS DU PONT (US) 2018-01-24 EP claimed
EP-2788366-A1 PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS E. I. Du Pont de Nemours and Company (US) 2014-10-15 EP claimed
WO-2013085620-A1 PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-06-13 WO claimed
US-20130150612-A1 PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2013-06-13 US claimed
EP-3635022-B1 METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME ETNA TEC LTD (US) 2025-05-21 EP disclosed
US-20240352208-A1 A Membrane and a Method of Making the Same AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2024-10-24 US disclosed
US-11820840-B2 Compound, polymer, pattern forming material, and manufacturing method of semiconductor device KIOXIA CORPORATION (JP) 2023-11-21 US disclosed
US-20230220130-A1 COMPOUND, POLYMER, PATTERN FORMING MATERIAL, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE KIOXIA CORPORATION (JP) 2023-07-13 US disclosed
US-20230145835-A1 Modulators of Alpha-4-beta-7 Integrin and MAdCAM QUANTUM INTELLIGENCE CORP. (KR) 2023-05-11 US disclosed
US-11639402-B2 Polymer for pattern forming material KIOXIA CORPORATION (JP) 2023-05-02 US disclosed
US-20230117826-A1 COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND METHODS OF USING SAME MOLECULAR TARGETING TECHNOLOGIES, INC. 2023-04-20 US disclosed
WO-1997046251-A9 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES 1998-06-04 WO disclosed
WO-1997046251-A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES LAJOLLA PHARMACEUTICAL COMPANY (US) 1997-12-11 WO disclosed
US-5616659-A Low flammability thermoset polymers SOUTHWEST RESEARCH INSTITUTE (US) 1997-04-01 US disclosed
EP-0583609-A1 Multiply-branched aliphatic-aromatic polyether esters and their preparation EASTMAN KODAK COMPANY (US) 1994-02-23 EP disclosed
EP-0437609-B1 OVERCOATING AGENT FOR THERMAL RECORDING MEDIUM ARAKAWA CHEM IND (JP) 1993-12-01 EP disclosed
US-5225522-A Multiply-branched aliphatic-aromatic polyesters and method for preparing multiply-branched aliphatic-aromatic polyesters EASTMAN KODAK COMPANY (US) 1993-07-06 US disclosed
US-5100949-A Graft copolymer of acrylic monomers onto polyvinyl alcohol, fatty acid ester of sucrose, nonsticking ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 1992-03-31 US disclosed
EP-0437609-A1 OVERCOATING AGENT FOR THERMAL RECORDING MEDIUM ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 1991-07-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820840-B2 Compound, polymer, pattern forming material, and manufacturing method of semiconductor device C9, H1-2, H1-3 CYP3A4 1524/4885CSNK2A1 2899/4885ACHE 4303/4885
US-20130150612-A1 PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS HRH3, PNN, H1-0 CYP3A4 2408/4885CSNK2A1 875/4885ACHE 3735/4885
US-20230145835-A1 Modulators of Alpha-4-beta-7 Integrin and MAdCAM ITGB7, ITGAM, ITGA4 CYP3A4 1865/4885CSNK2A1 1144/4885ACHE 1893/4885
US-20230117826-A1 COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND METHODS OF USING SAME ALDH1A2, PDE6C, ALDH1A3 CYP3A4 4418/4885CSNK2A1 4604/4885ACHE 930/4885
US-11639402-B2 Polymer for pattern forming material PUF60, METTL14, MECP2 CYP3A4 2687/4885CSNK2A1 4196/4885ACHE 2328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.